LPs
PersonMentions
2
Relationships
0
Events
0
Documents
1
Relationship Network
Loading... nodes
Interactive Network: Click nodes or edges to highlight connections and view details with action buttons.
Drag nodes to reposition. Node size indicates connection count.
Line color shows relationship strength: red (8-10), orange (6-7), yellow (4-5), gray (weak).
Use legend and help buttons in the graph for more guidance.
No relationships found for this entity.
No events found for this entity.
HOUSE_OVERSIGHT_024106.jpg
This document outlines the methodology used by New Leaf to calculate synthetic net returns for Sprout Healthcare Technology Portfolios. It explains the assumption of a standalone fund structure and provides a specific financial breakdown for 'Sprout IX,' detailing investments ($740M), fees ($120M), carried interest ($130M), and distributions to Limited Partners ($1,075M). The document bears a House Oversight Committee Bates stamp.
Financial methodology document / internal memo
2025-11-19
Total Received
$2,987,400,000.00
7 transactions
Total Paid
$0.00
0 transactions
Net Flow
$2,987,400,000.00
7 total transactions
| Date | Type | From | To | Amount | Description | Actions |
|---|---|---|---|---|---|---|
| N/A | Received | Sprout IX | LPs | $1,075,000,000.00 | Total Distributed to LPs | View |
| 2014-03-31 | Received | Growth II HCT | LPs | $56,300,000.00 | Net Distributed $s to LPs | View |
| 2014-03-31 | Received | Sprout VII HCT | LPs | $207,000,000.00 | Net Distributed $s to LPs | View |
| 2014-03-31 | Received | Sprout VIII HCT | LPs | $218,700,000.00 | Net Distributed $s to LPs | View |
| 2014-03-31 | Received | Sprout IX HCT | LPs | $1,071,500,000.00 | Net Distributed $s to LPs | View |
| 2014-03-31 | Received | NLV-I | LPs | $154,700,000.00 | Net Distributed $s to LPs | View |
| 2014-03-31 | Received | NLV-II | LPs | $204,200,000.00 | Net Distributed $s to LPs | View |
As Sender
0
As Recipient
0
Total
0
No communications found for this entity. Entity linking may need to be improved.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity